| Digg It |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Finance > Credit > Airline Credit Cards Are They Offering The Best Value? |
|
Digg It - Airline Credit Cards Are They Offering The Best Value?
There are more reward credit cards around now than ever before. There are cash back credit cards, points cards a According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product nd American Express even have a new nectar card out. One of the long running popular rewards has been the airlin ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in credit card. These are offered by many of the main card providers and they offer as their reward scheme the cha lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ce to collect airmiles as you spend. Airmiles are an extremely popular reward as they can be redeemed on major a here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe rlines for free or upgraded flights. However, the question customers have to keep asking themselves in this resp d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro ct is whether or not they offer the best value. Looking at airline credit cards as a whole, they typically rewa ucts have become life saving products for the pharmaceutical companies who doesnt have many innovative molecules in their product pipeline and have been inc d you with one airmile per pound spent. This seems fair enough but when you look at airmile redemption prices, y easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ou can see that it costs thousands of airmiles for even the shortest flights. For the vast majority of customers nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically it will take literally years to spend enough on the card to redeem a free flight, even within the UK. Some cust and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ mers will be able to add these miles to ones they also collect on flights and in this way build up miles faster. ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi If you compare this to other rewards however, you may be forced to ask yourself if they are worth the hassle. F ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a rst, compare this type of reward with similar rewards for using say a cash back credit card. While it will depen dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod on the specific circumstances of your card, it may well be the case that you would have got back enough cash to cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin buy a flight out right before ever getting enough miles to claim a free one. Also, if you are paying high inter tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen est on an outstanding balance then airmiles will be the last thing you should be thinking of. Rather you should t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel onsider getting a good balance transfer card that will allow you to switch your balance to it and enjoy a substa ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust tial interest free period on the balance. This will likely save you far more than any reward scheme will b e wor y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products h to you. Also, you may want a card that gives you lower rates on purchases if you do not pay off your balance i . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de full each month. As a general rule, if you dont pay off your entire balance in full each month, you should be elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ore concerned with interest rates and balance transfer possibilities than reward schemes on credit cards you use tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Getting Articles Published - Eight Steps for Trade Publications Top 10 Office Seating Mistakes People Make Buying An Office Chair
|